Jack West, MD of Swedish Cancer Institute discusses the use of durvalumab for patients with stage III non-small cell lung cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Durvalumab in stage III NSCLC
Jack West, MD of Swedish Cancer Institute discusses the use of durvalumab for patients with stage III non-small cell lung cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.